Document:

Exhibit 4.1

 

NONQUALIFIED STOCK OPTION GRANT AGREEMENT

 

HESTIA INSIGHT INC. 2021 STOCK INCENTIVE PLAN

 

This Stock Option Grant Agreement
(the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the
“Date of Grant”) by and between Hestia Insight Inc., a Nevada corporation (the “Company”), and the
individual named in Exhibit A hereto (the “Optionee”).

 

WHEREAS, the Company desires
to provide the Optionee an incentive to participate in the success and growth of the Company through the opportunity to earn a proprietary
interest in the Company; and

 

WHEREAS, to give effect to
the foregoing intention, the Company desires to grant the Optionee an option pursuant to the Hestia Insight Inc. 2021 Stock Incentive
Plan (the “Plan”) to acquire the Company’s common stock, par value $0.001 per share (the “Common
Stock”);

 

NOW, THEREFORE, in consideration
of the mutual covenants hereinafter set forth and for good and valuable consideration, the parties hereto agree as follows:

 

1. Grant.
The Company hereby grants the Optionee a Nonqualified Stock Option (the “Option”) to purchase up to the number of shares
of Common Stock (the “Shares”) set forth in Exhibit A hereto at the exercise price per Share (the “Exercise
Price”) set forth in Exhibit A, and on the vesting schedule set forth in Exhibit A, subject to the terms and conditions
set forth herein and the provisions of the Plan, the terms of which are incorporated herein by reference. Capitalized terms used but not
otherwise defined in this Grant Agreement shall have the meanings as set forth in the Plan.

 

2. Exercise
Period Following Termination of Service. This Option shall terminate and be canceled to the extent not exercised within ninety (90)
days after the Optionee’s Service terminates; provided that if such termination is due to the death or Disability of the Optionee,
this Option shall terminate and be canceled twelve (12) months from the date of termination of the Optionee’s Service; and provided,
further, that if Optionee’s Service terminates (other than for Cause) on or after a Change in Control, then the Option shall remain
exercisable until the Expiration Date. Notwithstanding the foregoing, in the event that the Optionee’s Service is terminated for
Cause, then the Option shall immediately terminate on the date of such termination of Service and shall not be exercisable for any period
following such date. In no event, however, shall this Option be exercised later than the Expiration Date set forth in Exhibit A
and in no event shall this Option be exercised for more Shares than the Shares which otherwise have become exercisable as of the date
of termination.

 

     

     

    

 

3. Method
of Exercise. This Option is exercisable by delivery to the Company of an exercise notice (the “Exercise Notice”)
in a form satisfactory to the Committee or by such other form or means as the Committee may permit or require. Any Exercise Notice shall
state or provide the number of Shares with respect to which the Option is being exercised (the “Exercised Shares”),
and include such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Optionee
may elect to make payment of the exercise price in cash or by check or by delivery to the Company of certificates representing shares
of outstanding Common Stock already owned by the Optionee that are owned free and clear of any liens, claims, encumbrances or security
interests together with stock powers duly executed and with signature guaranteed. In addition, the Optionee may make payment through a
“cashless exercise” such that without the payment of any funds, the undersigned may exercise the Option and receive the net
number of Shares equal to (x) the number of Shares as to which the Option is being exercised, multiplied by (y) a fraction, the numerator
of which is the Fair Market Value per share (on such date as is determined by the Committee) less the Exercise Price per Share, and the
denominator of which is such Fair Market Value per Share (the number of net Shares to be received shall be rounded down to the nearest
whole number). In the event payment is made by delivery of such Shares, said Shares shall be deemed to have a per Share value equal to
the Fair Market Value per Share on the date of exercise. Upon exercise of the Option by the Optionee and prior to the delivery of such
Exercised Shares, the Company shall have the right to require the Optionee to satisfy applicable Federal and state tax income tax withholding
requirements and the Optionee’s share of applicable employment withholding taxes in a method satisfactory to the Company. Notwithstanding
the foregoing, the Optionee may not exercise the Option by tender to the Company of Common Stock to the extent such tender would violate
the provisions of any law, regulation or agreement restricting the redemption of the Company’s Common Stock. Further, no Exercised
Shares shall be issued unless such exercise and issuance complies with the requirements relating to the administration of stock option
plans and other applicable equity plans under U.S. state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange
or quotation system on which the Common Stock is listed or quoted, and the applicable laws of any foreign country or jurisdiction where
stock grants or other applicable equity grants are made under the Plan; assuming such compliance, for income tax purposes the Exercised
Shares shall be considered transferred to the Optionee on the date the Option is exercised with respect to such Shares.

 

4. Covenants
Agreement. This Option shall be subject to forfeiture at the election of the Company in the event that the Optionee breaches any agreement
between the Optionee and the Company with respect to noncompetition, nonsolicitation, assignment of inventions and contributions and/or
nondisclosure obligations of the Optionee.

 

5. Taxes.

 

(a) 
By executing this Grant Agreement, Optionee acknowledges and agrees that Optionee is solely responsible for the satisfaction of any applicable
taxes that may be imposed on Optionee that arise as a result of the grant, vesting or exercise of the Option, including without limitation
any taxes arising under Section 409A of the Code (regarding deferred compensation) or Section 4999 of the Code (regarding golden parachute
excise taxes), and that neither the Company nor the Committee shall have any obligation whatsoever to pay such taxes or otherwise indemnify
or hold Optionee harmless from any or all of such taxes.

 

    -2-

     

    

 

(b) Notwithstanding
paragraph (a) above, if any amounts or benefits provided for in this Grant Agreement, when aggregated with any other payments or
benefits payable or provided to the Optionee (the “Total Payments”) would (i) constitute “parachute
payments” within the meaning of Section 280G of the Code (which will not include any portion of payments classified as
payments of reasonable compensation for purposes of Section 280G of the Code, including without limitation amounts allocated to any
restrictive covenants), and (ii) but for this Section 5(b), would be subject to the excise tax imposed by Section 4999 of the Code
(the “Excise Tax”), then the Total Payments will be either: (a) provided in full, or (b) provided as to such
lesser extent as would result in no portion of such Total Payments being subject to the Excise Tax, whichever of the foregoing
amounts, taking into account the applicable federal, state and local income and employment taxes and the Excise Tax, results in the
Optionee’s receipt on an after-tax basis of the greatest amount of the Total Payments, notwithstanding that all or some
portion of the Total Payments may be subject to the Excise Tax. To the extent any reduction in Total Payments is required by this
Section 5(b), such reduction shall occur to the payments and benefits in the order that results in the greatest economic present
value of all payments and benefits actually made to Optionee. Subject to Section 409A of the Code, such order of reductions shall be
determined by the Optionee. Unless the Company and the Optionee otherwise agree in writing, any determination required under this
Section 5(b) shall be made in writing by an independent public accounting firm mutually acceptable to the Company and the
Optionee (the “Accountants”) whose determination shall be conclusive and binding upon the Optionee and the
Company for all purposes. For purposes of making the calculations required by this Section 5(b), the Accountants may make reasonable
assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the
application of Sections 280G and 4999 of the Code. The Company and the Optionee shall furnish to the Accountants such information
and documents as the Accountants may reasonably request in order to make a determination under this Section 5(b). The Company
shall pay all fees and expenses of the Accountants.

 

6. Non-Transferability
of Option. This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may
be exercised during the lifetime of the Optionee only by the Optionee. The terms of the Plan and this Grant Agreement shall be binding
upon the executors, administrators, heirs, successors and assigns of the Optionee.

 

7. Securities
Matters. All Shares and Exercised Shares shall be subject to the restrictions on sale, encumbrance and other disposition provided
by Federal or state law. The Company shall not be obligated to sell or issue any Shares or Exercised Shares pursuant to this Grant Agreement
unless, on the date of sale and issuance thereof, such Shares are either registered under the Securities Act of 1933, as amended (the
“Securities Act”), and all applicable state securities laws, or are exempt from registration thereunder. Regardless
of whether the offering and sale of Shares under the Plan have been registered under the Securities Act, or have been registered or qualified
under the securities laws of any state, the Company at its discretion may impose restrictions upon the sale, pledge or other transfer
of such Shares (including the placement of appropriate legends on stock certificates or the imposition of stop-transfer instructions)
if, in the judgment of the Company, such restrictions are necessary in order to achieve compliance with the Securities Act or the securities
laws of any state or any other law.

 

    -3-

     

    

 

8. Investment
Purpose. The Optionee represents and warrants that unless the Shares are registered under the Securities Act, any and all Shares acquired
by the Optionee under this Grant Agreement will be acquired for investment for the Optionee’s own account and not with a view to,
for resale in connection with, or with an intent of participating directly or indirectly in, any distribution of such Shares within the
meaning of the Securities Act. The Optionee agrees not to sell, transfer or otherwise dispose of such Shares unless they are either (1)
registered under the Securities Act and all applicable state securities laws, or (2) exempt from such registration in the opinion of Company
counsel.

 

9. Lock-Up
Agreement. The Optionee hereby agrees that in the event that the Optionee exercises this Option during a period in which any directors
or officers of the Company have agreed with one or more underwriters not to sell securities of the Company, then, as a condition to such
exercise, the Optionee shall enter into an agreement, in form and substance satisfactory to the Company, pursuant to which the Optionee
shall agree to restrictions on transferability of the Shares comparable to the restrictions agreed upon by such directors or officers
of the Company.

 

10. Other
Plans. No amounts of income received by the Optionee pursuant to this Grant Agreement shall be considered compensation for purposes
of any pension or retirement plan, insurance plan or any other employee benefit plan of the Company or its subsidiaries, unless otherwise
expressly provided in such plan.

 

11. No
Guarantee of Continued Service. The Optionee acknowledges and agrees that the right to exercise the Option pursuant to the exercise
schedule hereof is earned only through continuous Service and such other requirements, if any, as are set forth in Exhibit A (and
not through the act of being hired, being granted an option or purchasing shares hereunder). The Optionee further acknowledges and agrees
that (i) this Grant Agreement, the transactions contemplated hereunder and the exercise schedule set forth herein do not constitute an
express or implied promise of continued employment or service for the exercise period or for any other period, and shall not interfere
with the Optionee’s right or the right of the Company or its Subsidiaries to terminate the employment or service relationship at
any time, with or without cause, subject to the terms of any written employment agreement that the Optionee may have entered into with
the Company or any of its Subsidiaries; and (ii) the Company would not have granted this Option to the Optionee but for these acknowledgements
and agreements.

 

    -4-

     

    

 

12. Entire
Agreement; Governing Law. The Plan is incorporated herein by reference. The Plan and this Grant Agreement constitute the entire agreement
of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the
Company and the Optionee with respect to the subject matter hereof, and may not be amended to materially impair the rights of the Optionee
without the Optionee’s consent; provided, however, that no action of the Board or the Committee that alters or affects the tax treatment
of the Option shall be considered to materially impair any rights of the Optionee. In the event of any conflict between this Grant Agreement
and the Plan, the Plan shall be controlling, except as otherwise specifically provided in the Plan. This Grant Agreement shall be construed
under the laws of the State of Nevada, without regard to conflict of laws principles.

 

13. Opportunity
for Review. Optionee and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan
and this Grant Agreement. The Optionee has reviewed the Plan and this Grant Agreement in their entirety, has had an opportunity to obtain
the advice of counsel prior to executing this Grant Agreement and fully understands all provisions of the Plan and this Grant Agreement.
The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions
relating to the Plan and this Grant Agreement. The Optionee further agrees to notify the Company upon any change in the residence address
indicated herein.

 

14. Section
409A. This Option is intended to be excepted from coverage under Section 409A and shall be administered, interpreted and
construed accordingly. The Company may, in its sole discretion and without the Optionee’s consent, modify or amend the terms of
this Grant Agreement, impose conditions on the timing and effectiveness of the exercise of the Option by Optionee, or take any other action
it deems necessary or advisable, to cause the Option to be excepted from Section 409A (or to comply therewith to the extent the Company
determines it is not excepted).

 

15. Recoupment.
In the event the Company restates its financial statements due to material noncompliance with any financial reporting requirements under
applicable securities laws, any shares issued pursuant to this Agreement for or in respect of the year that is restated, or the prior
three years, may be recovered to the extent the shares issued exceed the number that would have been issued based on the restatement.
In addition and without limitation of the foregoing, any amounts paid hereunder shall be subject to recoupment in accordance with The
Dodd–Frank Wall Street Reform and Consumer Protection Act and any implementing regulations thereunder, any clawback policy adopted
by the Company or as is otherwise required by applicable law or stock exchange listing conditions.

 

[Signature Page Follows]

 

    -5-

     

    

 

IN WITNESS WHEREOF, the parties hereto have executed
this Grant Agreement as of the date set forth in Exhibit A.

 

	 	
    HESTIA INSIGHT INC.

	 	 
	 	By: 	/s/ Edward Lee
	 	 	Name: Edward Lee
	 	 	Title: CEO
	 	 
	 	
    OPTIONEE

	 	 
	 	/s/ Eugene Cha
	 	Name: Eugene Cha

 

    -6-

     

    

 

EXHIBIT A

 

NONQUALIFIED STOCK OPTION GRANT AGREEMENT

 

HESTIA INSIGHT INC.

 

	(a)	Optionee’s Name:  Eugene Cha
	 	 
	(b)	Date of Grant:  January 4, 2022
	 	 
	(c)	Number of Shares Subject to the Option: 60,000
	 	 
	(d)	Exercise Price:  $3.50 per Share
	 	 
	(e)	Expiration Date:  January 4, 2027
	 	 
	
    (f)
	
    Vesting Schedule: The Option
shall vest in equal amounts over a period of one (1) year at the rate of fifteen thousand (15,000) Shares per fiscal quarter at the end
of such quarter, commencing in the quarter in which the Optionee enters into this Grant Agreement, and pro-rated for the number of days
the Optionee serves on the Board during the fiscal quarter. Notwithstanding the foregoing, if the Optionee ceases to be a member of Board
at any time during the one (1) year vesting period for any reason (such as resignation, withdrawal, death, disability or any other reason),
then any un-vested Options shall be irrefutably forfeited.

	 	 
	(g)	Notwithstanding anything contained herein
    to the contrary, if a “Change in Control” (as defined in the Plan) occurs prior to the cessation of the Optionee’s “Service”
    (as defined in the Plan), then the Option, to the extent not then vested, shall become fully (100%) vested immediately prior to the date
    of such Change in Control.

 

	 	/s/ EL
(Initials)	 
	 	
    Optionee
	 
	 	 	 
	 	/s/ EC
(Initials)	 
	 	Company Signatory	 

 

    -7-Exhibit 10.1

 

DIRECTOR AGREEMENT

 

This DIRECTOR AGREEMENT is
made as of the 4th day of January, 2022 (the “Agreement”), by and between Hestia Insight Inc., a Nevada corporation
(the “Company”), and Eugene Cha, an individual (the “Director”).

 

WHEREAS, the Board of Directors
of the Company (the “Board”) approved the appointment of the Director, and desires to enter into an agreement with the Director
with respect to such appointment;

 

WHEREAS, the Director’s
appointment will be effective upon execution of this Agreement; and

 

WHEREAS, the Director is willing
to accept such appointment and to serve the Company on the terms set forth herein and in accordance with the provisions of this Agreement.

 

NOW, THEREFORE, in consideration
of the mutual covenants contained herein, the parties hereto agree as follows:

 

1. Position. Subject to the terms and provisions of this Agreement, the Company shall cause the Director to be appointed as a member
of the Board, and the Director hereby agrees to serve the Company in such position, upon the terms and conditions hereinafter set forth,
provided, however, that the Director’s continued service on the Board after the next annual stockholders’ meeting
shall be subject to approval by the Company’s stockholders.

 

2. Duties. (a) During the Directorship Term (as defined herein), the Director shall make reasonable business efforts to attend all
Board meetings, serve on appropriate subcommittees as reasonably requested by the Board, make himself available to the Company at mutually
convenient times and places, attend external meetings and presentations, as appropriate and convenient, and perform such duties, services
and responsibilities, and have the authority commensurate to such position.

 

(b) The
Director will use his best efforts to promote the interests of the Company. The Company recognizes that the Director (i) is or may become
a full-time executive employee of another entity and that his responsibilities to such entity must have priority and (ii) sits or may
sit on the board of directors of other entities. Notwithstanding the same, the Director will use reasonable business efforts to coordinate
his respective commitments so as to fulfill his obligations to the Company and, in any event, will fulfill his legal obligations as a
Director. Other than as set forth above, the Director will not, without the prior notification to the Board, engage in any other business
activity which could materially interfere with the performance of his duties, services and responsibilities hereunder or which is in violation
of the reasonable policies established from time to time by the Company, provided that the foregoing shall in no way limit his
activities on behalf of (i) any current employer and its affiliates or (ii) the board of directors of any entities on which he currently
sits. At such time as the Board receives such notification, the Board may require the resignation of the Director if it determines that
such business activity does in fact materially interfere with the performance of the Director’s duties, services and responsibilities
hereunder.

 

     

     

    

 

3. Compensation.

 

(a) Stock Option. The Director shall receive, upon execution of this Agreement or at such time as options are available for issuance pursuant
to qualified stock option plan, a non-qualified stock option to purchase up to Sixty Thousand (60,000) shares of the Company’s common
stock at an exercise price of $3.50 per share. Such option shall be exercisable for a period of five years. The option shall vest in equal
amounts over a period of one (1) year at the rate of Fifteen Thousand (15,000) shares per fiscal quarter at the end of such quarter, commencing
in the quarter in which the Director enters into this Agreement, and pro-rated for the number of days the Director serves on the Board
during the fiscal quarter. Notwithstanding the foregoing, if the Director ceases to be a member of Board at any time during the one (1)
year vesting period for any reason (such as resignation, withdrawal, death, disability or any other reason), then any un-vested options
shall be irrefutably forfeited.

 

(b) During the Directorship Term, the Company will pay you a fee of US$150.00 for attending any Board meetings, which are generally expected
to occur every two to three months during the Directorship Term. The fee will be paid by wire to your nominated bank account. Your fees
shall be subject to adjustment periodically as determined by the Board.

 

(c) Independent Contractor. The Director’s status during the Directorship Term shall be that of an independent contractor and not, for
any purpose, that of an employee or agent with authority to bind the Company in any respect. All payments and other consideration made
or provided to the Director under this Section 3 shall be made or provided without withholding or deduction of any kind, and the Director
shall assume sole responsibility for discharging all tax or other obligations associated therewith.

 

(d) Expense Reimbursements. During the Directorship Term, the Company shall reimburse the Director for (i) all reasonable out-of-pocket expenses
incurred by the Director in attending any in-person meetings, provided that the Director complies with the generally applicable
policies, practices and procedures of the Company for submission of expense reports, receipts or similar documentation of such expenses,
and (ii) any costs associated with filings required to be made by the Director or any of the entities managed or controlled by Director
to report beneficial ownership or the acquisition or disposition of securities of the Company. Any reimbursements for allocated expenses
(as compared to out-of-pocket expenses of the Director) must be approved in advance by the Company.

 

    2

     

    

 

4. Directorship Term. The “Directorship Term,” as used in this Agreement, shall mean the period commencing on the date
hereof and terminating on the earlier of (i) the one (1) year anniversary of the date hereof, (ii) the date of the next annual stockholders’
meeting at which the Director is not elected to serve on the Board, and (iii) the earliest of the following to occur:

 

(a) the death of the Director;

 

(b) the termination of the Director from his membership on the Board by the mutual agreement of the Company and the Director;

 

(c) the removal of the Director from the Board by the majority stockholders of the Company; and

 

(d) the resignation by the Director from the Board.

 

5. Director’s Representation and Acknowledgment. The Director represents to the Company that his execution and performance of
this Agreement shall not be in violation of any agreement or obligation (whether or not written) that he may have with or to any person
or entity, including without limitation, any prior or current employer. The Director hereby acknowledges and agrees that this Agreement
(and any other agreement or obligation referred to herein) shall be an obligation solely of the Company, and the Director shall have no
recourse whatsoever against any officer, director, employee, stockholder, representative or agent of the Company or any of their respective
affiliates with regard to this Agreement.

 

6. Director Covenants.

 

(a) Unauthorized Disclosure. The Director agrees and understands that in the Director’s position with the Company, the Director has
been and will be exposed to and receive information relating to the confidential affairs of the Company, including, but not limited to,
technical information, business and marketing plans, strategies, customer information, other information concerning the Company’s
products, services, promotions, development, financing, expansion plans, business policies and practices, and other forms of information
considered by the Company to be confidential, and proprietary and in the nature of trade secrets. The Director agrees that during the
Directorship Term and thereafter, the Director will keep such information confidential and will not disclose such information, either
directly or indirectly, to any third person or entity without the prior written consent of the Company; provided, however,
that (i) the Director shall have no such obligation to the extent such information is or becomes publicly known or generally known in
the Company’s industry other than as a result of the Director’s breach of his obligations hereunder and (ii) the Director
may, after giving prior notice to the Company to the extent practicable under the circumstances, disclose such information to the extent
required by applicable laws or governmental regulations or judicial or regulatory process. This confidentiality covenant has no temporal,
geographical or territorial restriction. Upon termination of the Directorship Term, the Director will promptly return to the Company and/or
destroy at the Company’s direction all property, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence,
tapes, disks, cards, surveys, maps, logs, machines, technical data, other product or document, and any summary or compilation of the foregoing,
in whatever form, including, without limitation, in electronic form, which has been produced by, received by or otherwise submitted to
the Director in the course or otherwise as a result of the Director’s position with the Company during or prior to the Directorship
Term, provided that the Company shall retain such materials and make them available to the Director if requested by him in connection
with any litigation against the Director under circumstances in which (i) the Director demonstrates to the reasonable satisfaction of
the Company that the materials are necessary to his defense in the litigation and (ii) the confidentiality of the materials is preserved
to the reasonable satisfaction of the Company.

 

    3

     

    

 

(b) Non-Solicitation. During the Directorship Term and for a period of three (3) years thereafter, the Director shall not interfere with the
Company’s relationship with, or endeavor to entice away from the Company, any person who, on the date of the termination of the
Directorship Term and/or at any time during the one year period prior to the termination of the Directorship Term, was an employee or
customer (including those reasonably expected to be a customer) of the Company or otherwise had a material business relationship with
the Company.

 

(c) Remedies. The Director agrees that any breach of the terms of this Section 6 would result in irreparable injury and damage to the Company
for which the Company would have no adequate remedy at law. The Director therefore also agrees that in the event of said breach or any
threat of breach, the Company shall be entitled to an immediate injunction and restraining order to prevent such breach and/or threatened
breach and/or continued breach by the Director and/or any and all entities acting for and/or with the Director, without having to prove
damages or paying a bond, in addition to any other remedies to which the Company may be entitled at law or in equity. The terms of this
paragraph shall not prevent the Company from pursuing any other available remedies for any breach or threatened breach hereof, including,
but not limited to, the recovery of damages from the Director. The Director acknowledges that the Company would not have entered into
this Agreement had the Director not agreed to the provisions of this Section 6.

 

(d) The provisions of this Section 6 shall survive any termination of the Directorship Term, and the existence of any claim or cause of action
by the Director against the Company, whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement
by the Company of the covenants and agreements of this Section 6.

 

7. Indemnification. The Company agrees to indemnify the Director for his activities as a member of the Board as set forth in the Director
and Officer Indemnification Agreement attached hereto as Exhibit A.

 

8. Non-Waiver of Rights. The failure to enforce at any time the provisions of this Agreement or to require at any time performance
by the other party hereto of any of the provisions hereof shall in no way be construed to be a waiver of such provisions or to affect
either the validity of this Agreement or any part hereof, or the right of either party hereto to enforce each and every provision in accordance
with its terms. No waiver by either party hereto of any breach by the other party hereto of any provision of this Agreement to be performed
by such other party shall be deemed a waiver of similar or dissimilar provisions at that time or at any prior or subsequent time.

 

    4

     

    

 

9. Notices. Every notice relating to this Agreement shall be in writing and shall be given by e-mail, personal delivery, overnight
delivery or by registered or certified mail, postage prepaid, return receipt requested; to:

 

If to the Company:

 

Hestia Insight Inc.

400 S. 4th Street, Suite 500

Las Vegas, NV 89101

Attn: Edward Lee

E-mail:

 

with a copy (which shall not
constitute notice) to:

 

If to the Director:

 

Eugene Chin-Chuan Cha

Phone:

E-mail:

 

Either of the parties hereto may change their
address for purposes of notice hereunder by giving notice in writing to such other party pursuant to this Section 9.

 

10.  Binding
Effect/Assignment. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs,
executors, personal representatives, estates, successors (including, without limitation, by way of merger) and assigns, as applicable.
Notwithstanding the provisions of the immediately preceding sentence, neither the Director nor the Company shall assign all or any portion
of this Agreement without the prior written consent of the other party.

 

11.  Entire
Agreement. This Agreement (together with the other agreements referred to herein) sets forth the entire understanding of the parties
hereto with respect to the subject matter hereof and supersedes all prior agreements, written or oral, between them as to such subject
matter.

 

12.  Severability.
If any provision of this Agreement, or any application thereof to any circumstances, is invalid, in whole or in part, such provision or
application shall to that extent be severable and shall not affect other provisions or applications of this Agreement.

 

    5

     

    

 

13.  Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada, without reference to the
principles of conflict of laws. All actions and proceedings arising out of or relating to this Agreement shall be heard and determined
in any court in the State of New York and the parties hereto hereby consent to the jurisdiction of such courts in any such action or proceeding;
provided, however, that neither party hereto shall commence any such action or proceeding unless prior thereto the parties
have in good faith attempted to resolve the claim, dispute or cause of action which is the subject of such action or proceeding through
mediation by an independent third party.

 

14.  Legal
Fees. The parties hereto agree that the non-prevailing party in any dispute, claim, action or proceeding between the parties hereto
arising out of or relating to the terms and conditions of this Agreement or any provision thereof (a “Dispute”), shall reimburse
the prevailing party for reasonable attorney’s fees and expenses incurred by the prevailing party in connection with such Dispute;
provided, however, that the Director shall only be required to reimburse the Company for its fees and expenses incurred
in connection with a Dispute if the Director’s position in such Dispute was found by the court, arbitrator or other person or entity
presiding over such Dispute to be frivolous or advanced not in good faith.

 

15.  Modifications.
Neither this Agreement nor any provision hereof may be modified, altered, amended or waived except by an instrument in writing duly signed
by the party to be charged.

 

16.  Tense
and Headings. Whenever any words used herein are in the singular form, they shall be construed as though they were also used in the
plural form in all cases where they would so apply. The headings contained herein are solely for the purposes of reference, are not part
of this Agreement and shall not in any way affect the meaning or interpretation of this Agreement.

 

17.  Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which together
shall constitute one and the same instrument.

 

[-Signature Page Follows-]

 

    6

     

    

IN WITNESS WHEREOF, the Company
has caused this Director Agreement to be executed by authority of its Board of Directors, and the Director has hereunto set his hand,
on the day and year first above written.

 

HESTIA INSIGHT INC.

 

	By:	/s/ Edward Lee
	Name: 	Edward Lee
	Title:	Chief Executive Officer and Chairman

 

DIRECTOR

 

	/s/ Eugene Cha

	Eugene Cha, an individual

 

[Signature page to Director Agreement]

 

    7

     

    

 

EXHIBIT A

 

DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT

 

[Exhibit A to Director Agreement]

 

    8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]